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Detailed information about patients with infections is required to ensure appropriate choice of treat-
ment. Although white blood cell (WBC) counts, and C-reactive protein (CRP) levels are useful diagnostic
indicators of infections, more rapid and easily assayed indicator(s) could improve diagnosis. Moreover, it
is of pivotal importance to distinguish bacteria or viruses as causative pathogens. Overall, TLR2 and TLR4
expression levels in neutrophils derived from individuals (n ¼ 118) with bacterial (n ¼ 37) and viral
(n ¼ 34) infections were higher than those in control samples (n ¼ 47). Signiﬁcant higher levels of TNF-a
in patients with both types of the infection were observed, and those of IL-4, IL-8, IL-10, and IL-12 also
were observed in the present study. Levels of IL-2, IL-8, and IL-10 on day 1 post-viral infection were
signiﬁcantly higher than those on day 1 post-bacterial infection. Therefore, there is a possibility that IL-4,
IL-8, IL-10, IL-12 and TNF-amight be biomarkers for infections, in addition to WBC counts and CRP levels,
and that IL-2, IL-8 or IL-10 are potentially able to distinguish between bacterial and viral infections.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Japanese Society of Chemotherapy and The
Japanese Association for Infectious Diseases. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In infections, the host innate immune response is characterized
by the initial recognition of invading microbes by host “sentinel”
cells via Toll-like receptors (TLRs) or other pattern recognition
molecules [1]. The unlimited ability of the innate immune system
to recognize a wide range of pathogens is controlled by limited
numbers of microbial determinants expressed as pathogen-
associated molecular patterns (PAMPs) on infective organisms
[2,3]. The innate immune system uses germline-encoded receptors,
pattern-recognition receptors (PRRs), which are capable of recog-
nizing PAMPs. TLRs are a major family of PRRs involved in innate
immune responses to infectious agents [4,5], and are expressed in
various cell types, including circulating immune cells [5]. Among
TLRs, TLR2 and TLR4 are expressed on immune cells, including
peripheral neutrophils [6]; they are known as bacterial sensors, but
are also reported to be involved in the detection of viral infections
[7,8]. In addition, the interleukins, together with TNF-a and otherand Immunology, Advanced
e, Toho University,
Fax: þ81 (0)3 3766 0574.
onbehalf of Japanese Society of Chem
org/licenses/by-nc-nd/4.0/).chemokines, help to regulate inﬂammation and the intensity of the
immune response, and play a key role in activating the adaptive
immune response [9].
Neutrophils are very effective initial phagocytes, whose main
function on activation is thought to be the clearance of infecting
bacteria. To achieve this, these cells are equipped with a myriad of
antimicrobial molecules, grouped into oxidative and non-oxidative
systems. The complement system and neutrophil granulocytes are
also important for eliminating bacterial or fungal infections [10,11].
Cytokines are produced by the immune system in response to
invading pathogens [12]. A network of cytokine signals is essential
in modulation of the inﬂammatory response, clearance of patho-
gens, and subsequent repair of infected tissues. Cytokines can be
classiﬁed into two broad groups, based on their predominant
functions; IL-1b, IL-1a, IL-6, IL-8, IL-17, MIP-1, and TNF-a are pro-
inﬂammatory cytokines, whereas IL-4, IL-10, and TGF-b are anti-
inﬂammatory cytokines [13e15]. However, this classiﬁcation is
not absolute, as many cytokines are capable of exerting both pro-
and anti-inﬂammatory effects, depending on a variety of factors,
such as immunological and clinical contexts [16].
Infections are characterized by signs and symptoms overlapping
with other acute critical conditions, such as organ-speciﬁc infection
syndromes. Laboratory parameters, such as white blood cell (WBC)otherapyand The Japanese Association for Infectious Diseases. This is an open access article
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information. The distinction between bacterial and viral infections
is clinically important, but often very difﬁcult. This difﬁculty often
leads to unnecessary treatment with antibiotics, which is unfor-
tunate in the light of the growing problems with antibiotic resis-
tance [17,18]. Currently used methods that may aid in the
distinction between bacterial and viral infections are primarily
WBC counts and CRP levels [19,20], which have typical clinical
performances of 70%e80% sensitivity and speciﬁcity, resulting in a
high rate of misdiagnosis [21]. Recently, the new bacterial infection
markers, presepsin, procalcitonin, CD64 and proADM, have been
described [22e25]. Presepsin, procalcitonin, and CD64 are used for
the diagnosis of severe sepsis and septic shock, and proADM is used
for prediction of the prognosis of bacterial infections; hence, these
indicators are not suitable for the diagnosis of mild bacterial and
viral infections in outpatients who do not require admission. For
those patients, the development of more accurate laboratory
methods is warranted.
Although there is accumulating evidence concerning the re-
lationships among PAMPs, TLRs and levels of various cytokines in
infections, differences in the roles of TLRs and levels of cytokines
depending onwhether an infection is bacterial or viral are not clear.
The aim of this study was to analyze these in patients. Our studies
revealed, for the ﬁrst time, differences in TLR2 and TLR4 expression
levels in peripheral neutrophils and variation in the pattern of
plasma cytokine production between bacterial and viral infections.
2. Patients and methods
2.1. Study population
This study was reviewed and approved by the Toho University
Ethics Committee. (permissions No. 19032 and No. 24003). Patients
(n ¼ 118) were enrolled at ﬁrst visit to the pediatric outpatient
department at Toho University Omori Medical Center and received
medical treatment without being admitted to a hospital. Written
informed consent was obtained from their parents. Patients were
classiﬁed into three groups; 37 with bacterial infections, 34 with
viral infections, and 47 without infections as controls, after diag-
nosis by a pediatrician. Patients in control group were clinically
diagnosed with non-infectious and non-inﬂammatory diseases
(e.g., umbilicus and inguinal hernia). No patients in any group
developed immunological disorder. Patients in the bacterial and
viral infection groups were further classiﬁed into those with sam-
ples taken on day 1 (range,day 1 e <day 2), day 3 (day 3 e <day
4), or day 5 (day 5 e <day 6) after initial fever symptoms. These
patients were not continuously examined and were all different
individuals (i.e., more than one sample was not taken from any
patient). All patients in both infection groups were judged as hav-
ing “mild infection”, because they had recovered at the time of
subsequent visits. Patient characteristics and clinical laboratory
data are presented in Table 1 and causative microorganisms data
are presented in Table 2.
2.2. Isolation of neutrophils
Whole blood samples (2 mL) were obtained from all patients
before medical treatment. Each sample was centrifuged for sepa-
ration of cells and plasma, and the plasma was stored at 80 C
until analysis of cytokines. Red blood cells in the cellular fraction
were lysed with VersaLyse reagent (Beckman Coulter, Inc., CA, USA)
for 10 min. The remaining cells were washed with PBS and neu-
trophils isolated using a Human CD66abce MicroBead kit (Miltenyi
Biotec Inc., CA, USA). The isolation procedure was carried out
following a published method [26] and isolated neutrophils wereused immediately for quantitative analysis of TLR2 and TLR4
expression. The purity of the neutrophils was >99%.
2.3. Quantitative analysis of TLR2 and TLR4 expression
Neutrophils were stained with monoclonal antibodies CD282/
TLR2-PE or CD284/TLR4-PE for 30 min at 4 C.
The ﬂuorescence staining of neutrophils was measured by
FACSCalibur ﬂow cytometry (Becton Dickinson, NJ, USA). Data were
analyzed using FCS express 4 (De Novo Software, CA, USA).
2.4. Cytokine assays
Plasma IL-1a, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-17,
and TNF-a levels were measured using a Q-Plex Cytokine assay kit
(Quansys Biosciences, NJ, USA), following the manufacturer's in-
structions. When cytokine levels were lower than the detectable
limit, values were recorded as half of the Lower Limit of Detection.
2.5. Statistical analyses
Direct comparisons between any two groups were performed
using the ManneWhitney U test. P values < 0.05 were considered
statistically signiﬁcant. All statistical analyses were performed us-
ing GraphPad Prism version 6.0 (GraphPad Software, CA, USA).
3. Results
3.1. Clinical laboratory data in patients with bacterial or viral
infection
In patients with bacterial infections, total white blood cell and
neutrophil counts, and CRP levels were signiﬁcantly higher than
those in controls (Table 1). For patients with viral infections, white
blood cell and neutrophil counts were signiﬁcantly higher than
those of controls in the early period of infection (day 1 post-
infection); however, after day 3 post-infection counts decreased
and were not signiﬁcantly different to those of controls. CRP values
in patients with viral infections were signiﬁcantly higher than
those of controls at all time points.
3.2. TLR2 and TLR4 expression levels in neutrophils from infected
patients
TLR2 and TLR4 expression levels were signiﬁcantly higher in
neutrophils from infected patients compared to those in neutro-
phils of controls until day 5 post-infected outpatients with bacterial
infections (Fig. 1). In patients with viral infections, expression levels
of both TLR2 and TLR4 gradually increased over the course of the
infections.
There was a signiﬁcant difference in the level of TLR2 between
bacterial and viral infection groups on day 3 post-infection (Fig. 1).
3.3. Patterns of cytokine production in infected patients
The level of IL-1a was signiﬁcantly higher in samples from pa-
tients with bacterial infections than in those from controls until day
5 post-infection (Fig. 2). IL-1a, IL-1b and IL-2 cytokine levels were
signiﬁcantly elevated compared to those of controls on day 1 post-
viral infection and a signiﬁcantly higher level of IL-1b was also
observed on day 3 post-viral infection. IL-4, IL-8, IL-10, IL-12, IL-17,
and TNF-a levels were signiﬁcantly higher in samples from patients
with both bacterial and viral infections than in those from controls
until day 5 post-infection, except for that of IL-17 on day 5 post-
viral infection. IL-6 levels were signiﬁcantly higher than those of
Table 1
Patient characteristics and laboratory data.
DPI Male/female Age (months) (range) WBC (103/mL) NEUT (103/mL) CRP (mg/dL) (range)
Bacterial infections
Day 1 8/2 65.6 (2e179) 12.9 ± 6.9** 8.4 ± 5.0** 2.1** (0.2e8.8)
Day 3 4/10 58.7 (4e152) 9.6 ± 3.9 5.2 ± 3.0* 3.4** (0.1e5.8)
Day 5 6/7 54.2 (1e120) 11.7 ± 4.6** 6.6 ± 2.8** 3.5** (0.2e15.5)
Viral infections
Day 1 6/6 60.8 (3e181) 9.7 ± 3.1** 6.8 ± 3.3** 0.6** (0e1.8)
Day 3 8/4 47.8 (1e145) 7.0 ± 3.1 3.2 ± 2.7 0.8** (0e3.1)
Day 5 7/3 52.9 (7e155) 7.8 ± 4.5 2.8 ± 2.2 0.9** (0.1e4.2)
Control (without infections)
29/18 46.9 (0e193) 7.4 ± 2.6 2.7 ± 1.1 0.03 (0e0.2)
Age and CRP data are expressed as means and ranges. WBC and NEUT data are expressed as means ± SD. *p < 0.05, vs control. **p < 0.01, vs control. DPI, WBC, NEUT, and CRP
indicate days post infection, white blood cells, neutrophils, and C-reactive protein, respectively.
Table 2
Causative microorganism data.
Bacterial infections (n ¼ 37) Viral infections (n ¼ 34)
Day 1 n Day 1 n
Haemophilus inﬂuenzae 3 Enterovirus 6
Campylobacter jejuni 3 Respiratory syncytial virus 5
Mycoplasma pneumoniae 2 Inﬂuenza virus 1
Escherichia coli 1 Day 3
Streptococcus pyogenes 1 Respiratory syncytial virus 7
Day 3 Enterovirus 2
Haemophilus inﬂuenza 4 Inﬂuenza virus 1
Campylobacter jejuni 3 Cytomegalovirus 1
Streptococcus pneumoniae 3 Adenovirus 1
Mycoplasma pneumoniae 2 Day 5
Escherichia coli 1 Respiratory syncytial virus 4
Staphylococcus aureus 1 Epstein-Barr virus 3
Day 5 Inﬂuenza virus 2
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cantly higher than those of controls only on day 1 post-viral
infection. Levels of IL-5 were signiﬁcantly higher only on day 1
post-viral infection, compared with those of controls.
There were signiﬁcant differences in levels of IL-2, IL-8, and IL-
10 on day 1 post-infection between bacterial and viral infected
groups (Fig. 2).
The concentration of IL-8 on day 1 post-viral infection was
signiﬁcantly higher than those on days 3 and 5. The concentration
of IL-17 on day 5 post-viral infection was signiﬁcantly lower than
those on days 1 and 3 (Fig. 2).Fig. 1. Expression levels of TLR2 and TLR4 in neutrophils derived from patients with bacteria
line indicates the mean values of control samples from patients without infections. Data
respectively. y indicates p < 0.05 versus different type infection.4. Discussion
In the present study, to clarify whether or not the period after
initial fever symptoms (infections) inﬂuences the expression levels
of TLRs and cytokines in plasma samples, we grouped patients
roughly into days 1, 3, and 5 post-infection.
We analyzed the expression levels of TLR2 and TLR4 in neu-
trophils from children and levels of cytokines in plasma samples
from outpatients. An interesting report concerning the innate im-
mune response to infection and the role of cytokines in relation to
disease severity indicated that sera levels of cytokines were
considerably higher in severe than in mild infections or healthy
controls [9]. In general, severe infections develop from mild in-
fections (which comprise the majority of outpatient cases). How-
ever, there are few reports analyzing data from outpatients to
investigate the expression patterns of TLRs and cytokines relative to
time post-infection. In this study, for the ﬁrst time, we analyzed
these factors in outpatients with mild infections.
In patients with viral infections, plasma levels of the cytokines
analyzed in this study, other thanTNF-a, were considerably higher in
the early stage of infection. Cytokine concentrations were generally
highest on admission and those of IL-1, IL-6, IL-8, and IL-10, which
act as acute-phase proteins, decreased rapidly after admission, in
contrast with the more gradual kinetics of CRP [27e29]. These data
suggest that cytokines, other than TNF-a and CRP, are unlikely to be
useful biomarkers for viral infections. As TNF-a increases vascular
permeability and killing of intracellular pathogens [30], up-
regulation of TNF-a in plasma may be expected to persist during
infections. In patientswith bacterial infection, concentrations of IL-8,
IL-17, and TNF-awere higher than those of controls until day 5 post-
infection. One possible reason for these observationsmay be the role
of these cytokines in increasing the migration and function of neu-
trophils. In addition, IL-6, which inﬂuences levels of CRP, and IL-12,
which regulates production of INF-g, also remained high until day 5l and viral infections. A) Expression levels of TLR2. B) Expression levels of TLR4. Dotted
are expressed as means ± SD. * and ** indicate p < 0.05 and p < 0.01 versus control,
Fig. 2. Cytokine levels in patients with bacterial and viral infections. Plasma IL-1a, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-17, and TNF-a levels were measured using a
commercial ELISA kit. The dotted line indicates the mean values from control patients without infections. Data are expressed as means ± SD. * and ** indicate p < 0.05 and p < 0.01
versus control, respectively. y and yy indicate p < 0.05 and p < 0.01 versus different type infection, respectively. x and xx indicate p < 0.05 and p < 0.01 versus different day,
respectively.
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inﬂammatory cytokine, elevated in the sera of patients with in-
ﬂammatory diseases; therefore, although our samples were from a
different source (plasma, rather than sera), our results appear to be
consistent with their ﬁndings.
The results demonstrate that IL-4, IL-8, IL-10, IL-12, and TNF-a
levels elevated in the plasma of patients with viral infections, and
that IL-17 levels elevated only for the early stage of viral infections.
In addition, on the basis of the present data, assays of plasma levels
of IL-2, IL-8 or IL-10 may be able to distinguish between bacterial
and viral infections, which may assist in ensuring appropriate
choice of treatment.
Neutrophils aremarkedly increased in the circulation and tissues
during bacterial or fungal infections [31,32]. In contrast, although
they are the ﬁrst and predominant immune cell population
recruited to an affected site after viral infection, their contribution
to antiviral defense ismuch less appreciated [33]. The beneﬁcial role
of neutrophils has been conﬁrmed in viral infection models [34,35].The present study conﬁrmed that neutrophil counts in samples
from outpatients with bacterial infections were higher than those in
controls. Furthermore, in viral infections neutrophil counts were
also higher than those of controls in the early stage of infection.
These results indicate that neutrophils may play a pivotal role in, not
only bacterial, but also viral infections, at the early stage of infection.
Among the various PRRs, TLR2 and TLR4 have attracted themost
attention, because they mediate recognition of bacterial compo-
nents and drive the antibacterial functions of neutrophils [36]. In
addition, inﬂuenza A virus has been shown to upregulate TLR2
expression in neutrophils, thus increasing the production of H2O2
in response to TLR2 ligands such as peptidoglycans [37]. The pre-
sent study showed that the expression level of TLR2 in patient
samples might increase in the presence of sufﬁcient numbers of
pathogens. These data suggest that TLR2 expression may be a
marker for bacterial or viral infections. Since the expression pat-
terns of TLR4 in patients were similar to those of TLR2, TLR4 may
also be a biomarker for infections.
T. Yusa et al. / J Infect Chemother 23 (2017) 96e100100The polarization and plasticity of innate immune cell pop-
ulations has been reported [38]. By comparing various aspects of
the innate immune response, it appears that increased neutrophil
polarization towards a pro-inﬂammatory phenotype (increased IL-
12 and decreased IL-10) is responsible for improved clearance of
pathogens in the periphery [39], indicating that neutrophil polar-
ization inﬂuences bacterial clearance after infections. The present
study showed that IL-10 levels remained relatively elevated until
day 5 after both bacterial and viral infections in patients. In
contrast, levels of IL-12 were high in patients with early stage viral
infections and less so in patients with bacterial infections. Taken
together, these data show that differences in the degree of infection
and the timing of the assay may inﬂuence cytokine levels.
Finally, our observations provide a possibility that, not only TLR2
and TLR4 expressions on neutrophils, but also TNF-a, may be bio-
markers for infections, in addition to the known indicators, WBC
counts and CRP, and furthermore IL-2, IL-8, or IL-10 on the early
stage may be a biomarker for differentiation between bacterial and
viral infections. However, since the results have not been veriﬁed
using analysismethods such as the area under the receiver operating
characteristic (ROC) curve, present study was only proposed the
possibility of new indicators. On the other hand, no additional blood
samples are required to assay TLRs and cytokines in the plasma of
patients, since the drawing of whole blood is routine in patientswith
suspected infections. In addition, levels can be measured using a
commercial kit, which provides results simply and rapidly. In near
future, larger scale study might be required to conﬁrm present re-
sults because the number of samples was small in the present study.
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